CRISPR Therapeutics AG (CRSP) ended the recent trading session at $67.74, demonstrating a -6.98% change from the preceding day's closing price. This change lagged the S&P 500's 0.01% gain on the day.

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for oral ...

If you have $200, you could invest in one of each: a well-established pharma company with a track record of billion-dollar ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, ...

Becoming a millionaire through stock investing is possible, but it requires patience, discipline, and the acumen to make ...

The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.

In this Dylan Jovine’s Behind The Markets DNA Hacking review 2025, discover his CRISPR stock recommendation, newsletter ...

Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific ...